Validea’s guru fundamental report for HIMS & HERS HEALTH INC (HIMS) shows that it rates highest in the P/B Growth Investor model by Partha Mohanram, with a rating of 77%. The stock is a mid-cap growth stock in the Biotechnology & Drugs industry. The analysis looks at various criteria such as book/market ratio, return on assets, and cash flow from operations to assets. Partha Mohanram’s research on growth stocks has shown significant market outperformance. Validea is an investment research service that follows the strategies of investment legends like Warren Buffett and Peter Lynch.

Read more at Nasdaq: Validea Detailed Fundamental Analysis – HIMS